Invention Grant
US08632534B2 Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
有权
充血性阻塞性肺疾病（COPD）的不可逆电穿孔（IRE）
- Patent Title: Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
- Patent Title (中): 充血性阻塞性肺疾病（COPD）的不可逆电穿孔（IRE）
-
Application No.: US12754210Application Date: 2010-04-05
-
Publication No.: US08632534B2Publication Date: 2014-01-21
- Inventor: Robert Pearson , Mark V. Ortiz , Peter Callas
- Applicant: Robert Pearson , Mark V. Ortiz , Peter Callas
- Applicant Address: US NY Latham
- Assignee: AngioDynamics, Inc.
- Current Assignee: AngioDynamics, Inc.
- Current Assignee Address: US NY Latham
- Agent Ryan D. Artis
- Main IPC: A61B18/18
- IPC: A61B18/18
Abstract:
A method for treating Chronic Obstructive Pulmonary Disease (COPD) or chronic bronchitis to alleviate the discomforts of breathing by using non-thermal electroporation energy to ablate diseased portions of the lung including the bronchus, airways and alveoli which, in effect, opens the restrictive diseased portions thereby maximizing the overall surface area thereof causing improved airflow and uninhibited breathing.
Public/Granted literature
- US20100256628A1 Irreversible Electroporation (IRE) for Congestive Obstructive Pulmonary Disease (COPD) Public/Granted day:2010-10-07
Information query
